Opaleye Management Inc. Quant / Systematic

Location: Boston, MA

CIK: 0001595855 · Show all filings

Period: Q3 2015 (← Previous) (Next →)

Filing Date: Nov 13, 2015

Total Value: $203M (100.0% shares, 0.0% debt)

Holdings (49)

CHIMERIX INC 5.8%
Value $11.84M Shares 310,000 Est. Cost $23.65 Unrealized
RARE ULTRAGENYX PHARMACEUTICAL IN 5.2%
Value $10.59M Shares 110,000 Est. Cost $45.89 Unrealized +149.5%
CEMPRA INC 4.9%
Value $10.02M Shares 360,000 Est. Cost $9402.92 Unrealized
AXGN AXOGEN INC 4.3%
Value $8.734M Shares 2,120,000 Est. Cost $3.33 Unrealized +20.5%
MEDGENICS INC 4.1%
Value $8.277M Shares 1,058,400 Est. Cost $5.26 Unrealized
AMAG PHARMACEUTICALS INC 3.9%
Value $7.946M Shares 200,000 Est. Cost $53.91 Unrealized
IMPRIMIS PHARMACEUTICALS INC 3.8%
Value $7.736M Shares 1,205,000 Est. Cost $3098.93 Unrealized
ARIAD PHARMACEUTICALS INC 3.8%
Value $7.65M Shares 1,310,000 Est. Cost $6983.72 Unrealized
RETROPHIN INC 3.7%
Value $7.496M Shares 370,000 Est. Cost $20.71 Unrealized
FIBROGEN INC 3.5%
Value $7.124M Shares 325,000 Est. Cost $25.76 Unrealized
SUPN SUPERNUS PHARMACEUTICALS INC 3.2%
Value $6.454M Shares 460,000 Est. Cost $8.76 Unrealized +112.2%
ZS PHARMA INC 3.1%
Value $6.238M Shares 95,000 Est. Cost $44.25 Unrealized
INOTEK PHARMACEUTICALS CORP 3.0%
Value $6.042M Shares 642,800 Est. Cost $5.17 Unrealized
CARA THERAPEUTICS INC 2.9%
Value $5.93M Shares 415,000 Est. Cost $10.93 Unrealized
CDXS CODEXIS INC 2.7%
Value $5.492M Shares 1,620,000 Est. Cost $1.98 Unrealized +88.4%
EGRX EAGLE PHARMACEUTICALS INC 2.7%
Value $5.419M Shares 73,200 Est. Cost $70.86 Unrealized +17.4%
FLAMEL TECHNOLOGIES SA 2.5%
Value $5.056M Shares 310,000 Est. Cost $17.52 Unrealized
GERN GERON CORP 2.5%
Value $5.037M Shares 1,825,000 Est. Cost $2.63 Unrealized +37.7%
NBIX NEUROCRINE BIOSCIENCES INC 2.4%
Value $4.973M Shares 125,000 Est. Cost $30.55 Unrealized +58.2%
PROTALIX BIOTHERAPEUTICS INC 2.1%
Value $4.295M Shares 3,640,000 Est. Cost $1.71 Unrealized
OPHTHOTECH CORP 2.1%
Value $4.255M Shares 105,000 Est. Cost $13006.66 Unrealized
AFFIMED N V 1.8%
Value $3.642M Shares 590,300 Est. Cost $13.47 Unrealized
CYTRX CORP 1.8%
Value $3.614M Shares 1,525,000 Est. Cost $2.37 Unrealized
INTEC PHARMA LTD JERUSALEM 1.7%
Value $3.528M Shares 630,000 Est. Cost $5.60 Unrealized
AMARIN CORP PLC 1.7%
Value $3.397M Shares 1,760,000 Est. Cost $2.34 Unrealized
ZOGENIX INC 1.7%
Value $3.375M Shares 250,000 Est. Cost $1.68 Unrealized
TRILLIUM THERAPEUTICS INC 1.6%
Value $3.196M Shares 245,275 Est. Cost $9.00 Unrealized
TONIX PHARMACEUTICALS HLDG C 1.5%
Value $3.015M Shares 570,000 Est. Cost $6.52 Unrealized
BLUEPRINT MEDICINES CORP 1.4%
Value $2.774M Shares 130,000 Est. Cost $21.34 Unrealized
ADAMAS PHARMACEUTICALS INC 1.4%
Value $2.774M Shares 165,700 Est. Cost $17.42 Unrealized
MOMENTA PHARMACEUTICALS INC 1.3%
Value $2.626M Shares 160,000 Est. Cost $16.41 Unrealized
TGTX TG THERAPEUTICS INC 1.3%
Value $2.621M Shares 260,000 Est. Cost $14.90 Unrealized 0.0%
AGILE THERAPEUTICS INC 1.3%
Value $2.595M Shares 385,000 Est. Cost $7.00 Unrealized
AVINGER INC 1.3%
Value $2.574M Shares 175,000 Est. Cost $12.91 Unrealized
NIVALIS THERAPEUTICS INC 1.1%
Value $2.272M Shares 175,200 Est. Cost $12.97 Unrealized
XOMA CORP DEL 1.1%
Value $2.218M Shares 2,950,000 Est. Cost $1.44 Unrealized
FOAMIX PHARMACEUTICALS LTD 1.0%
Value $2.089M Shares 285,000 Est. Cost $8.20 Unrealized
TENAX THERAPEUTICS INC 0.9%
Value $1.905M Shares 635,000 Est. Cost $3.68 Unrealized
ACCELERATE DIAGNOSTICS INC 0.8%
Value $1.537M Shares 95,000 Est. Cost $19162.23 Unrealized
AURIS MED HLDG AG 0.6%
Value $1.264M Shares 355,000 Est. Cost $4.86 Unrealized
XENE XENON PHARMACEUTICALS INC 0.6%
Value $1.25M Shares 151,300 Est. Cost $9.93 Unrealized 0.0%
SAGE THERAPEUTICS INC 0.4%
Value $846K Shares 20,000 Est. Cost $42.30 Unrealized
EVOKE PHARMA INC 0.4%
Value $757K Shares 260,000 Est. Cost $474.90 Unrealized
INNOCOLL AG 0.3%
Value $695K Shares 55,543 Est. Cost $14.63 Unrealized
CELGENE CORP 0.3%
Value $547K Shares 340,000 Est. Cost $2800.00 Unrealized
ALDER PHARMACEUTICALS INC 0.3%
Value $527K Shares 16,100 Est. Cost $32.73 Unrealized
CYNAPSUS THERAPEUTICS INC 0.2%
Value $469K Shares 29,000 Est. Cost $16.17 Unrealized
BIOLINERX LTD 0.2%
Value $383K Shares 250,000 Est. Cost $1426.15 Unrealized
TRACON PHARMACEUTICALS INC 0.1%
Value $119K Shares 12,172 Est. Cost $11.34 Unrealized